Karen Brabham, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 39 Private Road 1201, New Brockton, AL 36351 Phone: 334-330-0060 |
James Duhaime, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 39 Private Road 1201, New Brockton, AL 36351 Phone: 334-330-0060 |
Felecia Toney, ALC Counselor Medicare: Not Enrolled in Medicare Practice Location: 39 Private Road 1201, New Brockton, AL 36351 Phone: 334-330-0060 |
Joseph Peeples Iv, ALC Counselor Medicare: Not Enrolled in Medicare Practice Location: 39 Private Road 1201, New Brockton, AL 36351 Phone: 334-330-0060 |
Theresa Mcclelland, ALC Counselor Medicare: Not Enrolled in Medicare Practice Location: 39 Private Road 1201, New Brockton, AL 36351 Phone: 334-330-0060 Fax: 334-894-5408 |
Cheryl L Donaldson Counselor Medicare: Not Enrolled in Medicare Practice Location: 39 Private Road 1201, New Brockton, AL 36351 Phone: 334-330-0060 |
News Archive
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers.
Biodesix, Inc., a company developing and commercializing molecular diagnostics for personalized medicine, announced today that the United States Patent and Trademark Office has awarded to the Company patent number 7,736,905. The patent provides coverage for the Company's first product, VeriStrat®, which is used by physicians to help guide therapy for patients with advanced lung cancer. The allowed claims are directed towards the serum-based identification of patients likely to benefit from epidermal growth factor targeted therapy.
Inter Press Service on Thursday examined how an increasing number of women living with HIV/AIDS in the Caribbean face stigma, discrimination and gender-based violence that is linked to the spread of the disease. UNAIDS reports that women overall now account for half of the population living with HIV in the Caribbean, compared with 30% in 1999. Women ages 15 to 24 account for 62% of the entire HIV-positive population in the Caribbean.
The most common subtypes of bipolar disorder, bipolar I and bipolar II, stem-at least in part-from different biological causes, according to a new study published in Biological Psychiatry.
MPI Research, a preclinical Contract Research Organization (CRO), announced that it will be collaborating with Kineta, Inc, a Seattle-based privately held biotechnology company specializing in clinical advancement of drugs that modulate and enhance the human immune system.
› Verified 8 days ago